SI9111427B - Heterociklične spojine - Google Patents
Heterociklične spojine Download PDFInfo
- Publication number
- SI9111427B SI9111427B SI9111427A SI9111427A SI9111427B SI 9111427 B SI9111427 B SI 9111427B SI 9111427 A SI9111427 A SI 9111427A SI 9111427 A SI9111427 A SI 9111427A SI 9111427 B SI9111427 B SI 9111427B
- Authority
- SI
- Slovenia
- Prior art keywords
- group
- methoxy
- alkyl
- compound
- compounds according
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 3
- -1 1-methoxy-1-methylethyl Chemical group 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 2
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- LDCMOCGAIMMZPI-UHFFFAOYSA-N 2-methylundec-2-enoic acid Chemical compound CCCCCCCCC=C(C)C(O)=O LDCMOCGAIMMZPI-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012374 esterification agent Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909018330A GB9018330D0 (en) | 1990-08-21 | 1990-08-21 | Heterocyclic compounds |
| GB919104770A GB9104770D0 (en) | 1991-03-07 | 1991-03-07 | Heterocyclic compounds |
| YU142791A YU48079B (sh) | 1990-08-21 | 1991-08-20 | Heterociklična jedinjenja |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9111427A SI9111427A (en) | 1996-12-31 |
| SI9111427B true SI9111427B (sl) | 2000-10-31 |
Family
ID=26297540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9111427A SI9111427B (sl) | 1990-08-21 | 1991-08-20 | Heterociklične spojine |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5587374A (fr) |
| EP (1) | EP0495953B1 (fr) |
| JP (2) | JP3151215B2 (fr) |
| KR (1) | KR0169147B1 (fr) |
| CN (1) | CN1030917C (fr) |
| AP (1) | AP238A (fr) |
| AT (1) | ATE106887T1 (fr) |
| AU (1) | AU647178B2 (fr) |
| CA (1) | CA2067741C (fr) |
| CY (1) | CY2037A (fr) |
| CZ (1) | CZ280942B6 (fr) |
| DE (1) | DE69102415T2 (fr) |
| DK (1) | DK0495953T3 (fr) |
| ES (1) | ES2054502T3 (fr) |
| FI (1) | FI97136C (fr) |
| HK (1) | HK19495A (fr) |
| HR (1) | HRP940556B1 (fr) |
| HU (2) | HUT61024A (fr) |
| IE (1) | IE66122B1 (fr) |
| IL (1) | IL99248A (fr) |
| MX (1) | MX9100743A (fr) |
| MY (1) | MY106997A (fr) |
| NO (1) | NO300176B1 (fr) |
| NZ (1) | NZ239474A (fr) |
| OA (1) | OA09578A (fr) |
| PL (1) | PL169425B1 (fr) |
| PT (1) | PT98729B (fr) |
| SG (1) | SG169494G (fr) |
| SI (1) | SI9111427B (fr) |
| SK (1) | SK278470B6 (fr) |
| WO (1) | WO1992003437A1 (fr) |
| YU (1) | YU48079B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9104838D0 (en) * | 1991-03-07 | 1991-04-17 | Glaxo Spa | Heterocyclic compounds |
| AP294A (en) * | 1992-08-31 | 1993-12-28 | Glaxo Spa | "10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo-(7.2.0.0.3.8) undec-2-ene-2-carboxylic acid derivatives". |
| GB9218781D0 (en) * | 1992-09-04 | 1992-10-21 | Glaxo Spa | Heterocyclic derivatives |
| IN188720B (fr) * | 1997-11-06 | 2002-11-02 | Panacea Biotec Ltd | |
| CA2465336C (fr) | 2001-11-05 | 2009-04-28 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveaux composes carbapenem |
| US7468364B2 (en) * | 2003-04-08 | 2008-12-23 | Dainippon Sumitomo Pharma Co., Ltd. | Carbapenem compounds |
| EP1785426A4 (fr) * | 2004-09-03 | 2008-02-20 | Dainippon Sumitomo Pharma Co | Nouveau dérivé de carbapénème |
| US20090029964A1 (en) * | 2005-03-25 | 2009-01-29 | Makoto Sunagawa | Novel carbapenem compound |
| EP2085084A1 (fr) | 2008-01-29 | 2009-08-05 | LEK Pharmaceuticals D.D. | Utilisation d'inhibiteur de lactamases bêta et sa combinaison avec les antibiotiques de lactamases bêta |
| EP2135871A1 (fr) * | 2008-06-18 | 2009-12-23 | LEK Pharmaceuticals D.D. | Nouveaux antibiotiques trinem et inhibiteurs de beta-lactamases |
| CN110869016B (zh) | 2017-05-08 | 2023-09-12 | 葛兰素史密斯克莱知识产权发展有限公司 | 用于治疗分枝杆菌感染的山费培南或其盐或酯 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1433131A (en) * | 1972-03-13 | 1976-04-22 | Astra Laekemedel Ab | Penicillins |
| GB1425571A (en) * | 1972-03-13 | 1976-02-18 | Astra Laekemedel Ab | Penicillins and cephaosporins |
| DE2811514A1 (de) * | 1977-03-19 | 1978-09-21 | Beecham Group Ltd | Ester der 7-oxo-1-azabicyclo eckige klammer auf 3.2.0 eckige klammer zu hept- 2-en-2-carbonsaeure und deren derivate, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zubereitungen |
| US4374848A (en) * | 1981-09-14 | 1983-02-22 | Merck & Co., Inc. | 6-(1-Hydroxyethyl)cyclonocardicin |
| US4374849A (en) * | 1981-09-14 | 1983-02-22 | Merck & Co., Inc. | 6-Amidocyclonocardicins |
| CZ435990A3 (cs) | 1989-09-08 | 1999-11-17 | Glaxo S.P.A. | Kyselina 10-(1-hydroxyethyl)-11-oxo-1-azatricyklo/7,2,0,03,8/-undec-2en-2-karboxylová a její deriváty, způsob jejich výroby, použití pro výrobu farmaceutických prostředků a farmaceutické prostředky s jejich obsahem |
| AU636913B2 (en) * | 1989-10-11 | 1993-05-13 | Takeda Chemical Industries Ltd. | Tricyclic carbapenem compounds |
| GB9104832D0 (en) * | 1991-03-07 | 1991-04-17 | Glaxo Spa | Heterocyclic compounds |
| GB9104838D0 (en) * | 1991-03-07 | 1991-04-17 | Glaxo Spa | Heterocyclic compounds |
-
1991
- 1991-08-20 CA CA002067741A patent/CA2067741C/fr not_active Expired - Fee Related
- 1991-08-20 SI SI9111427A patent/SI9111427B/sl unknown
- 1991-08-20 MX MX9100743A patent/MX9100743A/es unknown
- 1991-08-20 WO PCT/EP1991/001589 patent/WO1992003437A1/fr not_active Ceased
- 1991-08-20 EP EP91914351A patent/EP0495953B1/fr not_active Expired - Lifetime
- 1991-08-20 MY MYPI91001514A patent/MY106997A/en unknown
- 1991-08-20 DE DE69102415T patent/DE69102415T2/de not_active Expired - Fee Related
- 1991-08-20 PT PT98729A patent/PT98729B/pt not_active IP Right Cessation
- 1991-08-20 CZ CS921213A patent/CZ280942B6/cs not_active IP Right Cessation
- 1991-08-20 IE IE294491A patent/IE66122B1/en not_active IP Right Cessation
- 1991-08-20 CN CN91109093A patent/CN1030917C/zh not_active Expired - Fee Related
- 1991-08-20 NZ NZ239474A patent/NZ239474A/en unknown
- 1991-08-20 IL IL9924891A patent/IL99248A/en not_active IP Right Cessation
- 1991-08-20 DK DK91914351.1T patent/DK0495953T3/da active
- 1991-08-20 ES ES91914351T patent/ES2054502T3/es not_active Expired - Lifetime
- 1991-08-20 AU AU84212/91A patent/AU647178B2/en not_active Ceased
- 1991-08-20 HU HU921303A patent/HUT61024A/hu unknown
- 1991-08-20 SK SK1213-92A patent/SK278470B6/sk unknown
- 1991-08-20 AP APAP/P/1991/000320A patent/AP238A/en active
- 1991-08-20 AT AT91914351T patent/ATE106887T1/de not_active IP Right Cessation
- 1991-08-20 YU YU142791A patent/YU48079B/sh unknown
- 1991-08-20 PL PL91294573A patent/PL169425B1/pl unknown
- 1991-08-20 JP JP51366091A patent/JP3151215B2/ja not_active Expired - Fee Related
-
1992
- 1992-04-13 OA OA60190A patent/OA09578A/en unknown
- 1992-04-15 NO NO921521A patent/NO300176B1/no unknown
- 1992-04-16 FI FI921717A patent/FI97136C/fi active
- 1992-04-20 KR KR1019920700916A patent/KR0169147B1/ko not_active Expired - Fee Related
-
1994
- 1994-09-16 HR HR940556A patent/HRP940556B1/xx not_active IP Right Cessation
- 1994-12-01 SG SG169494A patent/SG169494G/en unknown
-
1995
- 1995-02-09 HK HK19495A patent/HK19495A/en not_active IP Right Cessation
- 1995-02-14 US US08/388,515 patent/US5587374A/en not_active Expired - Fee Related
- 1995-06-27 HU HU95P/P00455P patent/HU211584A9/hu unknown
-
1998
- 1998-02-20 CY CY203798A patent/CY2037A/xx unknown
-
2000
- 2000-05-17 JP JP2000144232A patent/JP3461786B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69332220T2 (de) | Lösliche analoga von probucol | |
| DE3005164C2 (de) | 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel | |
| US4006218A (en) | Potentiated medicaments | |
| Nudelman et al. | Novel anticancer prodrugs of butyric acid. 2 | |
| EP0038192B2 (fr) | Dérivés des 5-alkylsalicylanilides et procédé pour l'inhibition de la croissance des microorganisms | |
| IL154536A0 (en) | Immunoregulatory compounds and derivatives and methods of treating diseases therewith | |
| SI9111427B (sl) | Heterociklične spojine | |
| WO1999026632B1 (fr) | Phospholipides presentant une activite antimicrobienne avec ou sans presence d'agents antimicrobiens | |
| US6121317A (en) | Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing | |
| EP0049593B1 (fr) | Acide 1-éthyl-6-fluoro-1,4-dihydro-4-oxo-7(1-pipérazinyl)-quinoléine-3-carboxylique et sels métalliques utiles en thérapie des brûlures | |
| WO2012041934A1 (fr) | 2-aminoimidazoles polysubstitués destinés à la lutte contre la formation de biofilms et leur procédé de production | |
| WO2008035243A2 (fr) | Composition pour le traitement de brûlures et de blessures | |
| ATE22078T1 (de) | 1-ethyl-6,8-difluor-1,4-dihydro-7-(1-imidazolyl - 4-oxochinolincarbonsaeurederivate, verfahren zu ihrer herstellung und antibakterielle zusammensetzungen. | |
| CA2386685A1 (fr) | Utilisation de derives de pleuromutiline pour le traitement transdermique de maladies bacteriennes | |
| CA2183486A1 (fr) | Derives de la prostaglandine | |
| US4522819A (en) | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid and metal salts thereof useful in burn therapy | |
| US5679711A (en) | Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents | |
| US5391558A (en) | Composition for accelerating healing of wound | |
| EP0439450B1 (fr) | Composition pharmaceutique | |
| FI67856C (fi) | Foerfarande foer framstaellning av ett antibakteriellt silversalt av fosfanilsyra | |
| JPH06505259A (ja) | 複素環式化合物 | |
| JP4077052B2 (ja) | 抗菌、抗真菌および抗原虫活性を有するカルニチンのビスアルカノイルエステル | |
| JPS61191685A (ja) | アルキレンヘテロ原子架橋により結合せしめられた２位置換基を有するカルバペネム類 | |
| CN119326725B (zh) | 注射用厄他培南钠的制备方法 | |
| EP0498243B1 (fr) | Sel de cetyltrimethylammonium avec la phosphomycine et composition le contenant, pour le traitement local d'infections vaginales et urètrales |